Royalty Pharma

Latest news

• Royalty Pharma Owns a Piece of 16 Blockbuster Drugs -- Is the Stock a Buy? (opens in a new tab)

  The Motley Fool · Oct 1, 2026

• Form 4 Royalty Pharma Plc For: 1 October By Investing.com (opens in a new tab)

  Investing.com Nigeria · Oct 1, 2026

• Royalty Pharma EVP Marshall Urist sells $238,812 in shares (opens in a new tab)

  Investing.com · Sep 30, 2026

• Royalty Pharma (NASDAQ:RPRX) EVP Marshall Urist Sells 4,126 Shares of Stock (opens in a new tab)

  MarketBeat · Sep 30, 2026

• A director acquires 642 shares in lieu of a $37,500 retainer at Royalty Pharma (RPRX). (opens in a new tab)

  Stock Titan · Sep 30, 2026

• 4,126 shares sold under a trading plan by Royalty Pharma (RPRX) EVP Marshall Urist. (opens in a new tab)

  Stock Titan · Sep 30, 2026

• RPRX: Blockbuster Royalties Were The Hook, Synthetic Financing Drives The Upside (opens in a new tab)

  Simply Wall Street · Sep 30, 2026

• If You Invested $100 In Royalty Pharma Stock 10 Years Ago, You Would Have This Much Today (opens in a new tab)

  Benzinga · Sep 29, 2026

• After tax other income/expense of Royalty Pharma Plc Class A – HAN:RPD (opens in a new tab)

  TradingView · Sep 29, 2026

• Form 144 Royalty Pharma plc For: 29 September By Investing.com (opens in a new tab)

  Investing.com Canada · Sep 29, 2026

• Royalty Pharma officer proposes $239K share sale | RPRX SEC Filing - Form 144 (opens in a new tab)

  Stock Titan · Sep 28, 2026

• Form 144 Royalty Pharma PLC For: 27 September By Investing.com (opens in a new tab)

  Investing.com UK · Sep 27, 2026

• Royalty Pharma (NASDAQ:RPRX) Rating Lowered to Buy at Wall Street Zen (opens in a new tab)

  MarketBeat · Sep 26, 2026

• Did AI Expansion Just Shift Royalty Pharma's (RPRX) Investment Narrative? (opens in a new tab)

  Simply Wall Street · Sep 26, 2026

• Form 4 Royalty Pharma Plc For: 25 September By Investing.com (opens in a new tab)

  Investing.com India · Sep 25, 2026

• Royalty Pharma EVP Christopher Hite sells $5.85m in shares (opens in a new tab)

  Investing.com · Sep 25, 2026

• Revolution Medicines Receives FDA Breakthrough Designation, Royalty Pharma Offers a Diversified Investment Path (opens in a new tab)

  NAI500 · Sep 25, 2026

• Royalty Pharma Eyes AI, China Growth While Navigating Biopharma Policy Shifts (opens in a new tab)

  es.tradingview.com · Sep 25, 2026

• Is Buying Royalty Pharma Stock a Safer Way to Bet on Revolution Medicines? (opens in a new tab)

  The Motley Fool · Sep 25, 2026

• Insider Selling: Royalty Pharma (NASDAQ:RPRX) EVP Sells $5,853,000.00 in Stock (opens in a new tab)

  MarketBeat · Sep 24, 2026

• Royalty Pharma(RPRX.US) Officer Sells US$5.85 Million in Common Stock (opens in a new tab)

  Moomoo · Sep 24, 2026

• A prearranged plan governed SCH Investment Partners’ sale of 100,000 Royalty Pharma (RPRX) shares. (opens in a new tab)

  Stock Titan · Sep 24, 2026

• Royalty Pharma at Bank of America Global Healthcare Conference: growth even with policy risks (opens in a new tab)

  Investing.com UK · Sep 23, 2026

• Andra AP fonden Lowers Stock Holdings in Royalty Pharma PLC $RPRX (opens in a new tab)

  MarketBeat · Sep 23, 2026

• Royalty Pharma (RPRX) Stock Looks Richly Priced After Its 136% Run (opens in a new tab)

  Yahoo Finance · Sep 23, 2026

• Royalty Pharma (RPRX) holder plans new sale after selling 350,000 shares (opens in a new tab)

  Stock Titan · Sep 22, 2026

• NewEdge Advisors LLC Raises Stock Position in Royalty Pharma PLC $RPRX (opens in a new tab)

  MarketBeat · Sep 21, 2026

• Royalty Pharma PLC $RPRX Shares Sold by Corient Private Wealth LP (opens in a new tab)

  MarketBeat · Sep 19, 2026

• Could Royalty Pharma’s (NASDAQ:RPRX) Story Be Changing Fast? (opens in a new tab)

  kalkinemedia.com · Sep 18, 2026

• Royalty Pharma PLC (NASDAQ:RPRX) Receives Consensus Recommendation of "Buy" from Analysts (opens in a new tab)

  MarketBeat · Sep 18, 2026